Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

For decades, the only viable tool to help stroke patients regain lost motor abilities — like walking or moving an arm — has ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

How to use caffeine to best effect. Advice, such as a social media claim that delaying caffeine intake in the morning by a ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That's ...

British Columbia clinicians have received new guidance about involuntary care for adults, including a directive that it ...

RIO DE JANEIRO - Rio de Janeiro police demolished on Tuesday a facility they dubbed a "drug trafficking resort," which they ...

As nations wrestle with complex global challenges, China demonstrates a commitment to cooperation that offers a roadmap for ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

KING COUNTY, Wash. — A King County woman was sentenced March 6 after pleading guilty to federal drug and gun charges stemming from a 2024 investigation. U.S. District Judge Lauren King sentenced ...

Liraglutide is part of a class of drugs known as GLP-1 receptor agonists ... But these connections are complex, and scientists are still unravelling the brain circuits involved in GLP-1 agonist ...

possession of a Class A controlled drug with intent to supply, possession of a Class B controlled drug, possession of a Class B controlled drug with intent to supply and possession of a Class C ...